These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21144836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides.
    Lee LV, Bower KE, Liang FS, Shi J, Wu D, Sucheck SJ, Vogt PK, Wong CH.
    J Am Chem Soc; 2004 Apr 21; 126(15):4774-5. PubMed ID: 15080670
    [Abstract] [Full Text] [Related]

  • 4. Development of high-throughput assay of lethal factor using native substrate.
    Kim J, Choi MK, Koo BS, Yoon MY.
    Anal Biochem; 2005 Jun 01; 341(1):33-9. PubMed ID: 15866525
    [Abstract] [Full Text] [Related]

  • 5. Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor.
    Lewis JA, Mongan J, McCammon JA, Cohen SM.
    ChemMedChem; 2006 Jul 01; 1(7):694-7. PubMed ID: 16902919
    [No Abstract] [Full Text] [Related]

  • 6. Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.
    Schepetkin IA, Khlebnikov AI, Kirpotina LN, Quinn MT.
    J Med Chem; 2006 Aug 24; 49(17):5232-44. PubMed ID: 16913712
    [Abstract] [Full Text] [Related]

  • 7. Guanidinylated 2,5-dideoxystreptamine derivatives as anthrax lethal factor inhibitors.
    Jiao GS, Cregar L, Goldman ME, Millis SZ, Tang C.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1527-31. PubMed ID: 16386899
    [Abstract] [Full Text] [Related]

  • 8. Examination of anthrax lethal factor inhibition by siderophores, small hydroxamates, and protamine.
    Thomas M, Castignetti D.
    J Microbiol Immunol Infect; 2009 Aug 15; 42(4):284-9. PubMed ID: 19949750
    [Abstract] [Full Text] [Related]

  • 9. Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease.
    Kimura RH, Steenblock ER, Camarero JA.
    Anal Biochem; 2007 Oct 01; 369(1):60-70. PubMed ID: 17586456
    [Abstract] [Full Text] [Related]

  • 10. Screening inhibitors of anthrax lethal factor.
    Tonello F, Seveso M, Marin O, Mock M, Montecucco C.
    Nature; 2002 Jul 25; 418(6896):386. PubMed ID: 12140548
    [Abstract] [Full Text] [Related]

  • 11. Cationic polyamines inhibit anthrax lethal factor protease.
    Goldman ME, Cregar L, Nguyen D, Simo O, O'Malley S, Humphreys T.
    BMC Pharmacol; 2006 Jun 08; 6():8. PubMed ID: 16762077
    [Abstract] [Full Text] [Related]

  • 12. Viral protease assay based on GAL4 inactivation is applicable to high-throughput screening in mammalian cells.
    Lawler JF, Snyder SH.
    Anal Biochem; 1999 Apr 10; 269(1):133-8. PubMed ID: 10094783
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of anthrax lethal factor microinjected into macrophage cells through Sendai virus envelopes.
    Swain PK, Sarkar NK, Sharma M, Goel S, Singh RP, Singh Y.
    Indian J Biochem Biophys; 1997 Apr 10; 34(1-2):186-91. PubMed ID: 9343949
    [Abstract] [Full Text] [Related]

  • 14. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R, Ribot WJ, Abshire TG, Jett M, Ezzell J.
    BMC Infect Dis; 2008 Sep 22; 8():124. PubMed ID: 18808698
    [Abstract] [Full Text] [Related]

  • 15. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F, Montecucco C.
    Mol Aspects Med; 2009 Dec 22; 30(6):431-8. PubMed ID: 19665472
    [Abstract] [Full Text] [Related]

  • 16. Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.
    Bannwarth L, Goldberg AB, Chen C, Turk BE.
    Chem Biol; 2012 Jul 27; 19(7):875-82. PubMed ID: 22840775
    [Abstract] [Full Text] [Related]

  • 17. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
    Gkazonis PV, Dalkas GA, Chasapis CT, Vlamis-Gardikas A, Bentrop D, Spyroulias GA.
    Biochem Biophys Res Commun; 2010 Jun 04; 396(3):643-7. PubMed ID: 20438702
    [Abstract] [Full Text] [Related]

  • 18. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor.
    Turk BE, Wong TY, Schwarzenbacher R, Jarrell ET, Leppla SH, Collier RJ, Liddington RC, Cantley LC.
    Nat Struct Mol Biol; 2004 Jan 04; 11(1):60-6. PubMed ID: 14718924
    [Abstract] [Full Text] [Related]

  • 19. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR, Shaker DS, Le UM, Cui Z.
    FEMS Immunol Med Microbiol; 2008 Mar 04; 52(2):169-79. PubMed ID: 18194342
    [Abstract] [Full Text] [Related]

  • 20. Inhibitors of anthrax lethal factor.
    Gaddis BD, Avramova LV, Chmielewski J.
    Bioorg Med Chem Lett; 2007 Aug 15; 17(16):4575-8. PubMed ID: 17574849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.